Literature DB >> 35650393

Global characterization of megakaryocytes in bone marrow, peripheral blood, and cord blood by single-cell RNA sequencing.

Weilong Zhang1, Changjian Yan2, Xiaoni Liu3, Ping Yang1, Jing Wang1, Yingtong Chen1, Weiyou Liu3, Shaoxiang Li4, Xiuru Zhang4, Gehong Dong4, Xue He5, Xiaoliang Yuan6, Hongmei Jing7.   

Abstract

Megakaryocytes (MK) are mainly derived from bone marrow and are mainly involved in platelet production. Studies have shown that MK derived from bone marrow may have immune function, and that MK from peripheral blood are associated with prostate cancer. Single-cell transcriptome sequencing can help us better understand the heterogeneity and potential function of MK cell populations in bone marrow (BM), peripheral Blood (PB), and cord blood (CB) of healthy and diseased people.We integrated more than 1.2 million single-cell transcriptome data from 132 samples of PB, BM, and CB from healthy individuals and patients from different dataset. We examined the MK (including MK and product of MK) by single-cell RNA sequencing data analysis methods and identification of MK-related protein expression by the Human Protein atlas. We investigate the relationship between the MK subtype and Non-Small Cell Lung Cancer (NSCLC) in 77 non-cancer and 402 NSCLC. We found that MK were widely distributed and the amount of MK in peripheral blood was more than that in bone marrow and there were specificity MK subtypes in peripheral blood. We found classical MK1 with typical MK characteristics and non-classical MK2 closely related to immunity which was the most common subtype in bone marrow and cord blood. Classical MK1 was closely related to Non-Small Cell Lung Cancer (NSCLC) and can be used as a diagnostic marker. MK2 may have potential adaptive immune function and play a role in tumor NSCLC and autoimmune diseases Systemic Lupus Erythematosus. MK have 14 subtypes and are widely distributed in PB, CB, and BM. MK subtypes are closely related to immunity and have potential to be a diagnostic indicator of NSCLC.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Year:  2022        PMID: 35650393     DOI: 10.1038/s41417-022-00476-z

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  48 in total

1.  QUANTITATIVE OBSERVATIONS OF CIRCULATING MEGAKARYOCYTES IN THE BLOOD OF PATIENTS WITH CANCER.

Authors:  R HUME; J T WEST; R A MALMGREN; E A CHU
Journal:  N Engl J Med       Date:  1964-01-16       Impact factor: 91.245

2.  The frequency of megakaryocytes in autopsy sections.

Authors:  R BRILL; M M HALPERN
Journal:  Blood       Date:  1948-03       Impact factor: 22.113

3.  Circulating micromegakaryocytes in myelodysplasia.

Authors:  W N Erber; A Jacobs; D G Oscier; A M O'Hea; D Y Mason
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

4.  Unusual finding of a megakaryocyte in a peripheral blood smear.

Authors:  Nam K Ku; Hooman Rashidi
Journal:  Blood       Date:  2017-12-07       Impact factor: 22.113

5.  Identification of circulating micromegakaryocytes in a case of erythroleukemia.

Authors:  K Yamauchi; J Miyauchi; T Nagao
Journal:  Cancer       Date:  1984-06-15       Impact factor: 6.860

6.  Migration of entire megakaryocytes through the marrow--blood barrier.

Authors:  M Tavassoli; M Aoki
Journal:  Br J Haematol       Date:  1981-05       Impact factor: 6.998

Review 7.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

8.  Circulating megakaryocytes.

Authors:  G B Scott
Journal:  Histopathology       Date:  1982-07       Impact factor: 5.087

Review 9.  The incredible journey: From megakaryocyte development to platelet formation.

Authors:  Kellie R Machlus; Joseph E Italiano
Journal:  J Cell Biol       Date:  2013-06-10       Impact factor: 10.539

10.  Hematopoietic stem cell transplantation alters susceptibility to pulmonary hypertension in Bmpr2-deficient mice.

Authors:  Alexi Crosby; Mark R Toshner; Mark R Southwood; Elaine Soon; Benjamin J Dunmore; Emily Groves; Stephen Moore; Penny Wright; Katrin Ottersbach; Cavan Bennett; Jose Guerrero; Cedric Ghevaert; Nicholas W Morrell
Journal:  Pulm Circ       Date:  2018-08-30       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.